PAC INFECTO-1 A5
Contenido
R EFERENCIAS

  1. Velasco Castrejón O, Guzmán Bracho C, Cruz Rodríguez J, González Domínguez F. Las Leishmaniasis con especial referencia a México. Publicación técnica del Indre No. 7, 1993.

  2. Andrade Narváez FJ, Simmonds-Díaz E, Rico-Aguilar S, Andrade-Narvaez M, Palomo-Cetina A, Canto-Lara Sbetal. Incidence of localized cutaneous lesihmaniasis (chiclero's ulcer) in México. Trans Roy Soc Med Hyg 1990; 84:219-220.

  3. Gradoni L, Gramiccia M. Leishmania infantum Tropism: Strain genotype or host immune status? Parasitology Today 1994; 10: 264-267.

  4. Velasco O, Savarino SJ, Walton B, Gam AA, Neva FA. Diffuse Cutaneous Leishmaniasis in México Am J Trop Med Hyg 1989; 41:280-288.

  5. Kreutzer RD. Genetic analysis of Leishmaniasis mexicana populations from Texas, Latin America and the Caribbean. Am J Trop Med Hyg 1990; 43:367-372.

  6. Kelly JM, Ward HM, Miles MA, Kendall G. Ashuttle vector which facilitates the expression of trasfected genes in Trypanosoma cruzi and Leishmania. Nuclei Acids Res 1992;20:3963-3969.

  7. Kelly JM, Taylor MC, Smith K, Hunter KJ, Fairlamb AH. Phenotype of recombinant Leishmania Donovani and Trypanosoma cruzi wich over-express trypanothione reductase. Sensivity towards agents thar are thought to induce oxidative stress. Eur J Biochem 1993; 18:29-37.

  8. Wong SY, Remington JS, Biology of Toxoplasma gondii. AIDS 1993; 7:299-316.

  9. Endo T, Yagita K, Yasuda T, Nakamura T. Detection and localization of actin in Toxoplasma gondii. Parasitol Res 1988;75:102-106.

  10. Joiner KA; Dubremetz JF. Toxoplasma gondii: A protozoan for the nineties. Infect Immun 1993;61:1169-1172.

  11. Velasco O, Sepúlveda Amor J, Gutiérrez G, Tapia Conyer R, Salvatierra-Izaba R. Encuesta nacional seroepidemiológica III. Toxoplasmosis. Epidemiología Sistema Nacional de Salud. 1990;5:161-172.

  12. Hernández Gaeta. Antiparasitarios. En: Espinosa López. Terapéutica en enfermedades infecciosas, Tomo IV. Intermédica S.A,1997;pp 663-676.

  13. Nagatake T, Hoang VT, Tegoshi T, et al. Pathology of Plasmodium falciparum malaria in Vietnam. Am J Trop Med Hyg 1992;47:259-64.

  14. Baird JK, Purnomo, Basri H, et al. Age-specific prevalence of Plasmodium falcuparum among six populations with limited histories of exposure to endemic mahria Am JTrop Med Hyg 1993;49:707-19.

  15. Steketee RW, Wirima JJ, Slutsker L, et al Malaria prevention in pregnancy: The effects of treatament and chemoprophylaxis on placental malaria infection, low birth weight and fetal, infant and child survival CDC-ARTS Publication 099-4048. Washintong, DC U.S. Dept of Health and Human Services: 1994.

  16. Nardin EH, Nussenzweith RS. T cell responses to pre-erytrocyt-in stages of malaria: Role in protection and vaccine development aganist pre-erytrocytic stages. Annu Rev Immunol 1993,11:687-727.

  17. Anonymous. World malaria sinuation in 1990.WHO Stat Q. 1992;45:257-66.

  18. Bottaso O, Cabrine J, Falcoff R. Successful treatament of antimony-resistant American mucocutaneos lesihmaniasis. Arch Dermatol 1992;128:996-7.

  19. Carvalho MR, Krieger MA, Almeida E, et al. Chagas disease diagnosis: Evaluation of different test in blood bank screning and study of sera samples inconclusive for convencional serology. Mem Inst Oswaldo Cruz 1992;87 (suppl 2):134.

  20. Brisseau JM, Cebron JP, Petit T, et al. Chagas myocarditis imported into France. Lancet 1988;7:1046.

  21. Lobel Ho, Bernard KW, Williams SL, et al. Effectivenss and tolerance of long-term malaria prophylaxis with mefloquine. JAMA 265-361,1991.

  22. Miller KO, Greenberg AE, Cambell CC. Treatament of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med 321;65:1989.

  23. Kuzoe PA. Perspectives in reseach on and control of African trypanosomiasis. Ann Trop Med Parasitol 85;33:1991.

  24. Badaro R, Falcoff E, Badaro FS, et al. Treatment of visceral leishmaniasis with petavalent antimony and interferon-I. N Engl J Med 322;16:1990.

  25. Berenguer J, Moreno S, Cercenado E, et al. Visceral leishmaniasis in patients infected with human inmunodeficiency virus (HIV). Ann Intern Med 111;129:1989.

  26. Grimaldi GJr, McMahon Pratt. Leishmaniasis and its etiologic agents in the New World: An overview. Prog Clin Parasitol 1991;2:73.

  27. Luft BJ, Remington Js. Toxoplasmic encepphalitis in AIDS, Clin Infect Dis 1992;15:211.

  28. Remingtong JS, McLeod R. Toxoplasmosis. En: Gorbach SL, Barlett JG, Blacklow NR (eds) Infectious Diseases. Philadelphia, WB Saunders, 1992, p. 1328.

  29. Thomason JL, Gelbart SM. Trichomonas vaginalis. Obstet Gyencol 1990;74 (part 2):536.

  30. Filice C et al. Parasitologic findings in percutaneous drainege of human hydatid liver cysts J. Infect Dis 161:1290,1990.

  31. Krogstad DJ. Echinococcol disease. Curr Clin Infect Dis 1991;11:52-60.

  32. Bacq Y, Besnier JM, Duong T, et al. Successful treatament of acute fascioliasis with bithionol Hepatology 1991;14:1066.

  33. Zijlstra-EE, Osman-OF. Ther direct agglutination test for diagnosis of visceral leishmaniasis under field conditions in Sudan: comparison of aqueous and freeze-dried antigens. Trans R Soc Trop Med Hyg 1997;91:671-3.

  34. Thakur-CP. A Comparison of intercostal and abdominal toutes of splenic aspiration and bone marrow aspiration in the diagnosis of visceral leishmaniasis. Trans R SocTrop Med Hyg 1997;91:668-70.

  35. Tayeh A, Jalouk L, Cairncross S. Twenty years of cutaneosus leishmaniasis in Aleppo, Syria. Trans R Soc Trop Med Hyg 1997;91:657-9.

  36. Sebastian JJ, García S, Soria MT. Visceral leishmaniasis diagnosed by colonoscopy J Clin Gastroenterol 1997; 25:691-2.

  37. Thakur CP, Narain S, Kumar N. Ampotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Ann Trop Med Parasitol 1997;91:611-6.

  38. Chakrabarti A, Jumar B. Atypical post-kala-azar dermal leishmaniasis resebling histoid leprosy. Lepr Rev 1997; 68:247-51.

  39. Alcais-A; Abel-L; David-C.Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia. Am-J-Trop_Med-Hyg. 1997 Jul; 57(1): 79-84.

  40. Sundar S, Reed S, Sharma S. Circulating T helper 1 (TTh1) cell-and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997;56:522-5.

  41. Velez I, Agudelo S, Puerta J. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med 1997;126:232-6.

  42. Maltezou HC, Petropoulos D. Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplatation. Bone Marrow Transplant 1997;20:879-81.

  43. Muñoz P, Muñoz RM, Palomo J. Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. Medicine Baltimore 1997;76:415-22.

  44. Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev 1997;10:401-18.

  45. Jensen WA, Kroe-DM, Kirsch CM. Diagnostic strategies for Pneumocystis carinii pneumonia. Semin Respir Infect 1997;12:70-8.

  46. Schneider RF, Rosen MJ. Pulmonary complications of HIV infection. Curr Opin Pulm Med 1997;3:151-8.

  47. Santamauro JT, Stover DE. Pneumocystis carinii pneumonia. Med Clin North Am 1997;81:299-318.

  48. Korraa H, Saadeh C. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole. South Med J 1996;89:272-7.

  49. Renoult E, Georges E, Biava MF. Toxoplasmosis in kidney transplant recipient: report of six cases and review. Clin Infect Dis. 1997; 24:625-34.

  50. Rodgers CA, Harris Jr. Ocular toxoplasmosis in HIV infection (editorial). Int J STD AIDS. 1996;7:307-9.

  51. Barat LM, Bioland PB. Drug resistance among malaria and other parasites. Infect Dis Clin North Am 1997;11:969-87.

  52. Bates I, Bedu Addo G. Chronic malaria and splenic lymphoma: clues to understanding lymphoma evolution. Leukemia 1997;11:2162-7.

  53. Croft A, Garner P. Mefloquine to prevent malaria: a systematic review of trials. BMJ 1997;315:1412-6.

  54. Marsh K, Snow RW. Host-parasite interaction and morbidity in malaria endemic areas. Philos Trans R Soc Lond B Biol Sci 1997;352:1385-94.

  55. Anderson K, Stamatiou S, Whtby M. Gamma delta T cells: Their inmunobiology and role in malaria infections. Int J Parasitol 1997;27:191-200.

  56. Stanley J. Malaria. Emerg Med Clin North Am 1997;15:113-55

  57. McCombie SC. Treatment seeking for malaria: a review of recent research. Soc Sci Med 1996;43:933-45.

  58. Blair JE. Protecting travelers against infections: inmunizations and other preventive strategies. Postgrad Med 1996;100:159-62, 165-6, 169-72.

  59. Olliaro P, Nervill C, LeBras J. Systematic review of amodiaquine tratment in uncomplicated malaria. Lancet 1996;348:1196-201.

  60. Lagrera S; Garcia Enguita MA, Martínez Gutiérrez F. A case of cardiac hydatidosis. Br JAnaesth 1997;79:671-3.

  61. Angulo JC, Escribano J, Diego A. Isolated retrovesical and extrarenal retroperitoneal hydatidosis: clinical study of 10 cases and literature review. J Urol 1998;159:76-82.

  62. Deghaide NH, Dantas RO, Donadi EA. HLA class I and II profiles of patients presenting with Chagas disease. Dig Dis Sci 1998;43:246-52.

  63. Cohen JE, Tsai EC, Ginsberg HJ. Pseudotumoral chagasic meningoencephalitis as the first manifestation of acquired inmunodeficiency syndrome. Surg Neurol 1998;49:324-7.

  64. Sartori AM, Shikanai Yasuda MA, Amato Neto V. Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas´disease, with reactivation of Chagas´disease causing cardiac disease in three patients. Clin Infect Dis 1998;26:177-9.

  65. Wincker P, Telleria J, Bosseno MF, Cardoso MA, Marques P. PCR-based diagnosis for Chagas´disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis. Parasitology 1997;114 (pt 4): 367-73.

  66. Higuchi MD, Ries MM, Aiello VD. Association of an increase in CD8 + T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 1997;56:485-9.

  67. Rosas F, Velasco V, Arboleda F. Catheter ablation of ventricular tachycardia in Chagasic cardiomyopathy. Clin Cardiol 1997;20:169-74.

  68. Kodama K. (Human fasciolasis: comparison of a fascioliasis: comparison of a fasciolicidal effect of bithionol and praziquantel). Kansenshogaku Zasshi. 1997;71:1162-7

  69. Narain K, Biswas D, Rajguru SK. Human distomatosis due to fasciola hepatica infection in Assam, India. J Commun Dis 1997;29:161-5.

  70. Tavares C, Freitas P, Alfonso C. Hepatic fasciolasis, Acta Med. Port 1997;10:213-6.

  71. Sotelo J, Escobedo F, Rodríguez Carbajal J, et al. Therapy of parenchymal brain cysticersosis with praziquantel. N Engl J Med 1984;310:1001-7.

  72. Sotel J, Escobedo F, Penagos P. Albendazole vs. praziquantel for therapy for neurocysticercosis: A controlled trial. Arch Neurol 1988;45:532-4.

  73. Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis: A long-term follow-up review of 92 cases. J Neurosurg 1987;66:686-9.

  74. Vázquez MI, Jung H, Sotelo J. Levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology 1987;37:1561-2.

  75. Adam RD. The biology of Giardia sp. Microbiol Rev 1991;55:706-732.

  76. Berkelman RL. Emerging infectious diseases in the Unites States 1993. J Infect Dis 1994;170:272-277.

  77. Berlin OG, Novak SM, Porschen RK, Long EG, Stelma GN, Schaeffer FW. Recovery of Cyclospora organisms from patients with prolonged diarrhea. Clin Infect Dis 1993;18:606-609.

  78. Bruckner DA. Amebiasis. Clin Microbiol Rev 1992;5:356-369.

  79. Current WL, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev 1991;4:325-358.

  80. Kappus KD, Lundgren RG, Juranek DD, Roberts JM, Spencer HC. Intestinal parasitism in the Unites States: update on a continuing problem. Am J Trop Med Hyg 1994;50:705-713.

  81. La Via WV. Parasitic gastroenteritis. Pediatr Ann 1994;23:556-560.

  82. Lewis DJ, Freedman AR. Giardia lamblia as an intestinal pathogen. Dig Dis 1992;10:102-111.

  83. Mannheimer SB, Soave R. Protozoal infections in patients with AIDS: cryptosporidiosis, isosporiasis, cyclosporiasis, and microsporidiosis. Infect Dis Clin North Am 1994;8:483-498.

  84. Marshall M, Naumovitz D, Ortega Y, Sterling CH. Waterborne protozoan pathogens. Clin Microbiol Rev 1997;10:67-85.

  85. Red Board Enfermedades infecciosas en Pediatría. Peter, Halsey, Marcuse, Pickering, eds. 23a ed. Ed médica Panamericana, Buenos Aires, 1996.

  86. Cedillo RR. Parasitosis más frecuentes III. En: Gámes EJ, Palacio TJ (eds): Introducción a la Pediatría. 6ª ed. Méndez Editores, México 1997:321-28.

  87. Hernández GD. Antiparasitarios. En: Espinoza LFR (eds): Terapia en enfermedades infecciosas. Corporativo Intermédica, México 1997:663-76

  88. The medical letter. Drugs for parasitic infections. The medical letter 1998;40:1-12.

  89. Stanford JP. Guide to antimicrobial therapy 1996. Dallas: Antimicrobial therapy Inc, 1996.

  90. Ruff AJ. Ascaris lumbricoides (roundworm). En: Donowitz LG (eds). Infection control in the child care center and preschool. 3ª. Ed, Williams & Wilkins, Pennsylvania 1996:94-96.

  91. Romero Cabello R, Guerrero LR, Muñóz García MR, Geyne Cruz A. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg 1997;91:701-3

  92. Biagy. Enfermedades parasitarias. 2ª ed. Reimpresión 1984, La Prensa Médica Mexicana, México, 233-300.

  93. Chester BP, Clifton RJ, Wayne EC. Parasitología clínica. 2ª ed. Salvat Editores S.A. México reimpresión 1994.

  94. Atlas A. Parasitología clínica. 3ª ed. Publicaciones Técnicas Mediterráneo Ltda, Chile, 1991.

  95. Marshal MM, Naumovitz D, Ortega Y, Sterling Ch. R. Waterborne protozoan pathogens. Clinic Microbiol Rev 1997;10:67-85.

  96. Weiss JB. DNA Probes and PCR for diagnosis of parasitic infections. Clin Microbiol Rev 1995;8:113-130.

  97. Valerie LNG, Yajko DM, Hadley K. Extrapulmonary pneumocystosis Clin Microbiol Rev 1997;10:401-410.

  98. Woods GL, Walker DII. Detection of infection or infectious agents by use of cytologic and histologic stains.

  99. Guerant WR, Thelman NM. Emerging enteric protozoa: Cryptosporidium, Cyclospora and Microsporidia. Emerging Infections Washington, D.C.: ASM Press, 1998:233-46.

  100. Fleck SL, Moody A-II. Diagnostic techniques in medical parasitology. Cambridge: Wright University Press, 1997.

  101. Leventhal R, Cheadle RF. Medical parasitology. Davis Company, 1997.

  102. Zeibig EA. Clinical parasitology. W.B. Sanders Co., 1997.
Contenido
Copyright © 2005 Dr. Scope. Derechos Reservados.
Diseño y Programación: Educación Médica Contínua